Diagnostic utility of plasma p‐tau217 differs by Alzheimer's disease tau‐based subtypes

Abstract Introduction Blood‐based biomarkers, most notably plasma phosphorylated tau (p‐tau)217, have transformed the diagnostic landscape of Alzheimer's disease (AD). Methods We applied an unsupervised machine learning approach to tau positron emission tomography (PET) imaging in 606 participants (...

Descrición completa

Detalles Bibliográficos

Principais autores:	Seyed Hani Hojjati, Tracy A. Butler, Seyed Javad Moosania Zare, Ali Reihanian, Mohammad Khalafi, Nancy Foldi, Sudhin Shah, Hasan Jafari, Yi Li, Liangdong Zhou, William Dartora, Krista Wartchow, Laura Beth J. McIntire, Gloria C. Chiang, for the Alzheimer's Disease Neuroimaging Initiative
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wiley 2025-10-01
Series:	Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Assuntos:	Alzheimer's disease atypical Alzheimer's disease blood biomarker phosphorylated tau217 tau positron emission tomography
Acceso en liña:	https://doi.org/10.1002/dad2.70227
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!